Eight of the most prominent test makers are navigating a whiplash marketplace.
Category: Daily Cover
How HCA Healthcare’s ‘Conservative’ Covid Strategy Reaped Dividends
Under the leadership of CEO Sam Hazen, the nearly 54-year-old company recorded higher revenue and profits in 2021 than before the pandemic.
Covid Year 3 Will Be Better, Experts Agree, Unless Rich Countries Ignore The Pandemic Elsewhere
The worst of the pandemic is behind us, experts told Forbes, in part because the first two years provided valuable tools for the continued fight against both Covid and future disease epidemics.
Pfizer’s CEO Reveals Negotiations With The Trump White House And How The Vaccine Was Priced
In an exclusive excerpt from Moonshoot, Dr. Albert Albert Bourla recalls the fraught diplomacy with Jared Kushner to distribute the Covid-19 shot at warp speed to America first—and then the rest of the world.
Forbes Blockchain 50 2022
Since our inaugural roundup of the Blockchain 50, published in 2019, the billion-dollar companies (minimum, by sales or market value) on our annual list have moved beyond test projects and now rely on “distributed ledger” technology to do serious work….
Meet The First Covid Testing Billionaire
Swabs for Covid testing made Copan CEO Stefania Triva a billionaire. But, despite countless buyout offers, she’s snubbing the dealmakers and keeping the company firmly in the family.
The French Duck Breeder That’s Helping To Vanquish Omicron
The company with an estimated $1 billion contract to make Covid-19 vaccines for the European Commission was best known until recently as a leader in the field of animal genetics.
Michael J. Fox’s Foundation Debuts Among Nation’s Top 100 Charities
Michael J. Fox Foundation for Parkinson’s Research joins the elite list for first time thanks to donations by Google co-founder Sergey Brin.
Softbank-Backed Mental Health Unicorn Cerebral Reneged On Salaries And Health Insurance For Hundreds Of Therapists
The company, which raised $300 million at a $4.8 billion valuation this month, changed the status of more than 200 employees from salaried to hourly workers in August and made their health insurance contingent on quotas in 2022.
The Billionaire Chairman Of Vaccine Maker Moderna Wants To Reinvent Scientific Entrepreneurship
Noubar Afeyan launched 70 companies by pushing researchers to ask what if their craziest ideas were true. With $17 billion and a model of “parallel entrepreneurship,” he can fund a lot of wild notions.
